Clinical Trials Directory

Trials / Completed

CompletedNCT01553604

Dressing Wear Time After Breast Augmentation With Prosthesis

Influence of Dressing Wear Time on Skin Colonization After Breast Augmentation With Prosthesis: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Daniela Francescato Veiga · Academic / Other
Sex
Female
Age
18 Months – 60 Years
Healthy volunteers
Accepted

Summary

This study was designed to determine whether the duration of dressing wear following augmentation mammaplasty influence skin colonization and eventually surgical site infections rates.

Detailed description

Augmentation mammaplasty is currently one of the most performed plastic surgery procedures. It is a clean operation, and surgical site infection (SSI) rates are low. However, a SSI, since a minor one, leads to the failure of the procedure. Thus, minimizing SSI risks is imperative. The Centers for Disease Control and Prevention (CDC) provides recommendations concerning prevention of SSI.No recommendation is offered for some practices, either because there is a lack of consensus regarding their efficacy or because of the available scientific evidence is insufficient to support their adoption. CDC´s "Guideline for Prevention of Surgical Site Infection" recommends protecting with a sterile dressing for 24 to 48 hours an incision that has been closed primarily. There is no recommendation to cover the incision beyond 48 hours. One major risk factor for SSI is the presence of bacteria at surgical site.Thus, this trial was designed to verify the influence of dressing wear time on skin colonization.

Conditions

Interventions

TypeNameDescription
PROCEDUREaugmentation mammaplastyDressing is removed on the first postoperative day
PROCEDUREaugmentation mammaplastyDressing is removed on the 6th postoperative day

Timeline

Start date
2013-07-01
Primary completion
2015-01-01
Completion
2015-09-01
First posted
2012-03-14
Last updated
2019-09-06

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01553604. Inclusion in this directory is not an endorsement.